Oruka Therapeutics (ORKA) Amortizatization of Intangibles (2015 - 2026)
Oruka Therapeutics' quarterly Amortizatization of Intangibles came in at $446000.0 in Q1 2026, down 75.18% year-on-year from $1.8 million in Q1 2025, and down 32.73% quarter-over-quarter from $663000.0 in Q4 2025.
Oruka Therapeutics has reported Amortizatization of Intangibles for 12 years, with the latest figure at $446000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 75.18% year-over-year to $446000.0; the trailing twelve-month figure through Mar 2026 stood at $3.7 million (up 98.26% YoY), and the FY2025 full-year result was $5.0 million, up 122.85% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $446000.0, down from $663000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.8 million in Q1 2025, with the low at $9000.0 in Q2 2024.
- Average Amortizatization of Intangibles over 5 years is $377600.0, with a median of $25000.0 recorded in 2023.
- Year-over-year, Amortizatization of Intangibles jumped 16600.0% in 2025 and tumbled 75.18% in 2026.
- Tracing ORKA's Amortizatization of Intangibles over 5 years: stood at $24000.0 in 2022, then decreased by 16.67% to $20000.0 in 2023, then sank by 55.0% to $9000.0 in 2024, then soared by 7266.67% to $663000.0 in 2025, then sank by 32.73% to $446000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $446000.0 (Q1 2026), $663000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | 446,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 446,000.00 |
| Mar 31, 2026 | 446,000.00 |
| Dec 31, 2025 | 663,000.00 |
| Dec 31, 2025 | 663,000.00 |
| Sep 30, 2025 | 1.04 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Jun 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 25,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | 24,000.00 |
| Dec 31, 2022 | 24,000.00 |
| Sep 30, 2022 | 24,000.00 |
| Sep 30, 2022 | 24,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Dec 31, 2021 | 23,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Jun 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 16,000.00 |
| Mar 31, 2021 | 14,000.00 |
| Mar 31, 2021 | 14,000.00 |
| Dec 31, 2020 | 14,000.00 |
| Dec 31, 2020 | 14,000.00 |
| Sep 30, 2020 | 24,000.00 |
| Sep 30, 2020 | 24,000.00 |
| Jun 30, 2020 | 25,000.00 |
| Jun 30, 2020 | 25,000.00 |
| Mar 31, 2020 | 22,000.00 |
| Mar 31, 2020 | 22,000.00 |
| Dec 31, 2019 | 22,000.00 |
| Dec 31, 2019 | 22,000.00 |
| Sep 30, 2019 | 17,000.00 |
| Sep 30, 2019 | 17,000.00 |
| Jun 30, 2019 | 16,000.00 |
| Jun 30, 2019 | 16,000.00 |
| Mar 31, 2019 | 16,000.00 |
| Mar 31, 2019 | 16,000.00 |
| Mar 31, 2018 | -2,000.00 |
| Mar 31, 2018 | -2,000.00 |
| Dec 31, 2017 | 60,000.00 |
| Dec 31, 2017 | 60,000.00 |
| Sep 30, 2017 | 360,000.00 |
| Sep 30, 2017 | 360,000.00 |
| Jun 30, 2017 | -181,000.00 |
| Jun 30, 2017 | -181,000.00 |
| Mar 31, 2017 | 90,000.00 |
| Mar 31, 2017 | 90,000.00 |
| Dec 31, 2016 | -61,000.00 |
| Dec 31, 2016 | -61,000.00 |
| Sep 30, 2016 | -217,000.00 |
| Sep 30, 2016 | -217,000.00 |
| Jun 30, 2016 | 60,000.00 |
| Jun 30, 2016 | 60,000.00 |
| Mar 31, 2016 | 57,000.00 |
| Mar 31, 2016 | 57,000.00 |
| Dec 31, 2015 | 56,000.00 |
| Dec 31, 2015 | 56,000.00 |
| Sep 30, 2015 | 55,000.00 |
| Sep 30, 2015 | 55,000.00 |
| Jun 30, 2015 | 47,000.00 |
| Jun 30, 2015 | 47,000.00 |
| Mar 31, 2015 | 31,000.00 |
| Mar 31, 2015 | 31,000.00 |